RecruitingEarly Phase 1NCT06989853

Methamphetamine and Troriluzole

Advancing Troiluzole as a Treatment for Methamphetamine Use Disorder: A Human Laboratory Study

Sponsor

William Stoops

Enrollment

40 participants

Start Date

Aug 25, 2025

Study Type

INTERVENTIONAL

Conditions

Methamphetamine Use Disorder

Summary

This will be a human laboratory study evaluating the influence of troriluzole treatment on the effects of methamphetamine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.

Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Methamphetamine and a drug called Placebo for people with methamphetamine use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.